CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0381
-0.0019 (-4.75%)
Oct 27, 2025, 3:32 PM EDT
CV Sciences Market Cap
CV Sciences has a market cap or net worth of $6.85 million as of October 28, 2025. Its market cap has decreased by -17.68% in one year.
Market Cap
6.85M
Enterprise Value
7.66M
Revenue
14.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 9, 2011, CV Sciences's market cap has increased from 3.71M to 6.85M, an increase of 84.51%. That is a compound annual growth rate of 4.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 6.85M | 9.91% |
| Dec 31, 2024 | 6.23M | 13.96% |
| Dec 29, 2023 | 5.47M | 10.51% |
| Dec 30, 2022 | 4.95M | -62.06% |
| Dec 31, 2021 | 13.04M | -72.32% |
| Dec 31, 2020 | 47.10M | -50.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |